{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:29:34Z","timestamp":1782570574238,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06372"],"award-info":[{"award-number":["23K06372"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06608"],"award-info":[{"award-number":["21K06608"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-025-10262-x","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:10:23Z","timestamp":1762233023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thrombomodulin-Induced Prevention of Peripheral Neuropathy in Oxaliplatin-Treated Mice Involves Complement C5a Inactivation and PAR1 Activation in Addition To HMGB1 Degradation"],"prefix":"10.1007","volume":"20","author":[{"given":"Kengo","family":"Maruo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Tomono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-807X","authenticated-orcid":false,"given":"Atsufumi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"10262_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2119\/molmed.2014.00176","volume":"20","author":"NM Agalave","year":"2015","unstructured":"Agalave NM, Svensson CI (2015) Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol Med 20:569\u2013578. https:\/\/doi.org\/10.2119\/molmed.2014.00176","journal-title":"Mol Med"},{"key":"10262_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ph14040307","author":"SY Alomar","year":"2021","unstructured":"Alomar SY, Gheit R, Enan ET, El-Bayoumi KS, Shoaeir MZ, Elkazaz AY, Al Thagfan SS, Zaitone SA, El-Sayed RM (2021) Novel mechanism for memantine in attenuating diabetic neuropathic pain in mice via downregulating the spinal HMGB1\/TRL4\/NF-kB inflammatory axis. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph14040307","journal-title":"Pharmaceuticals (Basel)"},{"key":"10262_CR3","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/sj.bjp.0704568","volume":"135","author":"S Asfaha","year":"2002","unstructured":"Asfaha S, Brussee V, Chapman K, Zochodne DW, Vergnolle N (2002) Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 135:1101\u20131106. https:\/\/doi.org\/10.1038\/sj.bjp.0704568","journal-title":"Br J Pharmacol"},{"key":"10262_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021221","volume":"25","author":"I Babkina","year":"2024","unstructured":"Babkina I, Savinkova I, Molchanova T, Sidorova M, Surin A, Gorbacheva L (2024) Neuroprotective effects of noncanonical PAR1 agonists on cultured neurons in excitotoxicity. Int J Mol Sci 25:1221. https:\/\/doi.org\/10.3390\/ijms25021221","journal-title":"Int J Mol Sci"},{"key":"10262_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(79)90048-9","volume":"165","author":"JP Brockes","year":"1979","unstructured":"Brockes JP, Fields KL, Raff MC (1979) Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165:105\u2013118. https:\/\/doi.org\/10.1016\/0006-8993(79)90048-9","journal-title":"Brain Res"},{"key":"10262_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55\u201363. https:\/\/doi.org\/10.1016\/0165-0270(94)90144-9","journal-title":"J Neurosci Methods"},{"key":"10262_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/labinvest.2010.183","volume":"91","author":"G Chen","year":"2011","unstructured":"Chen G, Yang Y, Gao X, Dou Y, Wang H, Han G, Wang R, Wang J, Wang L, Li X, Guo R, Xiao H, Shen B, Li Y (2011) Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis. Lab Invest 91:472\u2013483. https:\/\/doi.org\/10.1038\/labinvest.2010.183","journal-title":"Lab Invest"},{"key":"10262_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","volume":"261","author":"L Di Cesare Mannelli","year":"2014","unstructured":"Di Cesare Mannelli L, Pacini A, Micheli L, Tani A, Zanardelli M, Ghelardini C (2014) Glial role in oxaliplatin-induced neuropathic pain. Exp Neurol 261:22\u201333. https:\/\/doi.org\/10.1016\/j.expneurol.2014.06.016","journal-title":"Exp Neurol"},{"key":"10262_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bcp.2015.08.005","volume":"97","author":"K Fukami","year":"2015","unstructured":"Fukami K, Sekiguchi F, Yasukawa M, Asano E, Kasamatsu R, Ueda M, Yoshida S, Kawabata A (2015) Functional upregulation of the H2S\/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells. Biochem Pharmacol 97:300\u2013309. https:\/\/doi.org\/10.1016\/j.bcp.2015.08.005","journal-title":"Biochem Pharmacol"},{"key":"10262_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040399","volume":"9","author":"C Giorgio","year":"2021","unstructured":"Giorgio C, Zippoli M, Cocchiaro P, Castelli V, Varrassi G, Aramini A, Allegretti M, Brandolini L, Cesta MC (2021) Emerging role of C5 complement pathway in peripheral neuropathies: current treatments and future perspectives. Biomedicines 9:399. https:\/\/doi.org\/10.3390\/biomedicines9040399","journal-title":"Biomedicines"},{"key":"10262_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.bbrc.2017.11.079","volume":"495","author":"Y Hayashi","year":"2018","unstructured":"Hayashi Y, Tsujita R, Tsubota M, Saeki H, Sekiguchi F, Honda G, Kawabata A (2018) Human soluble thrombomodulin-induced blockade of peripheral HMGB1-dependent allodynia in mice requires both the lectin-like and EGF-like domains. Biochem Biophys Res Commun 495:634\u2013638. https:\/\/doi.org\/10.1016\/j.bbrc.2017.11.079","journal-title":"Biochem Biophys Res Commun"},{"key":"10262_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.114146","volume":"355","author":"K Hisaoka-Nakashima","year":"2022","unstructured":"Hisaoka-Nakashima K, Ohata K, Yoshimoto N, Tokuda S, Yoshii N, Nakamura Y, Wang D, Liu K, Wake H, Yoshida T, Ago Y, Hashimoto K, Nishibori M, Morioka N (2022) High-mobility group box 1-mediated hippocampal microglial activation induces cognitive impairment in mice with neuropathic pain. Exp Neurol 355:114146. https:\/\/doi.org\/10.1016\/j.expneurol.2022.114146","journal-title":"Exp Neurol"},{"key":"10262_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11481-017-9757-2","volume":"12","author":"Y Irie","year":"2017","unstructured":"Irie Y, Tsubota M, Ishikura H, Sekiguchi F, Terada Y, Tsujiuchi T, Liu K, Nishibori M, Kawabata A (2017) Macrophage-derived HMGB1 as a pain mediator in the early stage of acute pancreatitis in mice: targeting RAGE and CXCL12\/CXCR4 axis. J Neuroimmune Pharmacol 12:693\u2013707. https:\/\/doi.org\/10.1007\/s11481-017-9757-2","journal-title":"J Neuroimmune Pharmacol"},{"key":"10262_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/s0196-9781(02)00053-0","volume":"23","author":"A Kawabata","year":"2002","unstructured":"Kawabata A, Kawao N, Kuroda R, Tanaka A, Shimada C (2002) The PAR-1-activating peptide attenuates carrageenan-induced hyperalgesia in rats. Peptides 23:1181\u20131183. https:\/\/doi.org\/10.1016\/s0196-9781(02)00053-0","journal-title":"Peptides"},{"key":"10262_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00280-020-04135-8","volume":"86","author":"M Kotaka","year":"2020","unstructured":"Kotaka M, Saito Y, Kato T, Satake H, Makiyama A, Tsuji Y, Shinozaki K, Fujiwara T, Mizushima T, Harihara Y, Nagata N, Kurihara N, Ando M, Kusakawa G, Sakai T, Uchida Y, Takamoto M, Kimoto S, Hyodo I (2020) A placebo-controlled, double-blind, randomized study of Recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy. Cancer Chemother Pharmacol 86:607\u2013618. https:\/\/doi.org\/10.1007\/s00280-020-04135-8","journal-title":"Cancer Chemother Pharmacol"},{"key":"10262_CR16","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1096\/fj.07-8770com","volume":"21","author":"K Liu","year":"2007","unstructured":"Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, Nishibori M (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 21:3904\u20133916. https:\/\/doi.org\/10.1096\/fj.07-8770com","journal-title":"FASEB J"},{"key":"10262_CR17","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, Kelley MR, Lavino A, Lustberg MB, Paice JA, Schneider BP, Lavoie Smith EM, Smith ML, Smith TJ, Wagner-Johnston N, Hershman DL (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38:3325\u20133348. https:\/\/doi.org\/10.1200\/JCO.20.01399","journal-title":"J Clin Oncol"},{"key":"10262_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pain.2009.07.016","volume":"146","author":"L Martin","year":"2009","unstructured":"Martin L, Auge C, Boue J, Buresi MC, Chapman K, Asfaha S, Andrade-Gordon P, Steinhoff M, Cenac N, Dietrich G, Vergnolle N (2009) Thrombin receptor: an endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain 146:121\u2013129. https:\/\/doi.org\/10.1016\/j.pain.2009.07.016","journal-title":"Pain"},{"key":"10262_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/ITT.S58064","volume":"4","author":"S Martinotti","year":"2015","unstructured":"Martinotti S, Patrone M, Ranzato E (2015) Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immunotargets Ther 4:101\u2013109. https:\/\/doi.org\/10.2147\/ITT.S58064","journal-title":"Immunotargets Ther"},{"key":"10262_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02127-x","volume":"40","author":"L Micheli","year":"2021","unstructured":"Micheli L, Parisio C, Lucarini E, Vona A, Toti A, Pacini A, Mello T, Boccella S, Ricciardi F, Maione S, Graziani G, Lacal PM, Failli P, Ghelardini C, Di Cesare Mannelli L (2021) VEGF-A\/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody. J Exp Clin Cancer Res 40:320. https:\/\/doi.org\/10.1186\/s13046-021-02127-x","journal-title":"J Exp Clin Cancer Res"},{"key":"10262_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173196","volume":"880","author":"T Minami","year":"2020","unstructured":"Minami T, Takeda M, Sata M, Kato H, Yano K, Sakai T, Tsujita R, Kawasaki K, Ito A (2020) Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity. Eur J Pharmacol 880:173196. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173196","journal-title":"Eur J Pharmacol"},{"key":"10262_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1160\/TH14-05-0448","volume":"112","author":"LO Mosnier","year":"2014","unstructured":"Mosnier LO, Zlokovic BV, Griffin JH (2014) Cytoprotective-selective activated protein C therapy for ischaemic stroke. Thromb Haemost 112:883\u2013892. https:\/\/doi.org\/10.1160\/TH14-05-0448","journal-title":"Thromb Haemost"},{"key":"10262_CR23","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","volume":"120","author":"LO Mosnier","year":"2012","unstructured":"Mosnier LO, Sinha RK, Burnier L, Bouwens EA, Griffin JH (2012) Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood 120:5237\u20135246. https:\/\/doi.org\/10.1182\/blood-2012-08-452169","journal-title":"Blood"},{"key":"10262_CR24","doi-asserted-by":"publisher","first-page":"51059","DOI":"10.1074\/jbc.M306977200","volume":"278","author":"T Myles","year":"2003","unstructured":"Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ, Pearl RG, Leung LL (2003) Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 278:51059\u201351067. https:\/\/doi.org\/10.1074\/jbc.M306977200","journal-title":"J Biol Chem"},{"key":"10262_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073640","volume":"8","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Morioka N, Abe H, Zhang FF, Hisaoka-Nakashima K, Liu K, Nishibori M, Nakata Y (2013) Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1. PLoS ONE 8:e73640. https:\/\/doi.org\/10.1371\/journal.pone.0073640","journal-title":"PLoS ONE"},{"key":"10262_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tox.2016.07.016","volume":"365","author":"T Nishida","year":"2016","unstructured":"Nishida T, Tsubota M, Kawaishi Y, Yamanishi H, Kamitani N, Sekiguchi F, Ishikura H, Liu K, Nishibori M, Kawabata A (2016) Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats. Toxicology 365:48\u201358. https:\/\/doi.org\/10.1016\/j.tox.2016.07.016","journal-title":"Toxicology"},{"key":"10262_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.101976","volume":"79","author":"M Revel","year":"2025","unstructured":"Revel M, Merle NS (2025) Local and cell-intrinsic complement: the new player in cancer progression. Semin Immunol 79:101976. https:\/\/doi.org\/10.1016\/j.smim.2025.101976","journal-title":"Semin Immunol"},{"key":"10262_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112479","volume":"145","author":"F Sato","year":"2022","unstructured":"Sato F, Nakamura Y, Ma S, Kochi T, Hisaoka-Nakashima K, Wang D, Liu K, Wake H, Nishibori M, Morioka N (2022) Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson\u2019s disease. Biomed Pharmacother 145:112479. https:\/\/doi.org\/10.1016\/j.biopha.2021.112479","journal-title":"Biomed Pharmacother"},{"key":"10262_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010367","volume":"22","author":"F Sekiguchi","year":"2020","unstructured":"Sekiguchi F, Kawabata A (2020) Role of HMGB1 in chemotherapy-induced peripheral neuropathy. Int J Mol Sci 22:367. https:\/\/doi.org\/10.3390\/ijms22010367","journal-title":"Int J Mol Sci"},{"key":"10262_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.040","volume":"141","author":"F Sekiguchi","year":"2018","unstructured":"Sekiguchi F, Domoto R, Nakashima K, Yamasoba D, Yamanishi H, Tsubota M, Wake H, Nishibori M, Kawabata A (2018) Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: evidence for a neuroimmune crosstalk. Neuropharmacology 141:201\u2013213. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.040","journal-title":"Neuropharmacology"},{"key":"10262_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.pain.2010.03.023","volume":"149","author":"M Shibasaki","year":"2010","unstructured":"Shibasaki M, Sasaki M, Miura M, Mizukoshi K, Ueno H, Hashimoto S, Tanaka Y, Amaya F (2010) Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 149:514\u2013521. https:\/\/doi.org\/10.1016\/j.pain.2010.03.023","journal-title":"Pain"},{"key":"10262_CR32","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1189\/jlb.0108001","volume":"83","author":"V Shpacovitch","year":"2008","unstructured":"Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M (2008) Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 83:1309\u20131322. https:\/\/doi.org\/10.1189\/jlb.0108001","journal-title":"J Leukoc Biol"},{"key":"10262_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s40122-022-00431-8","volume":"11","author":"MC Spera","year":"2022","unstructured":"Spera MC, Cesta MC, Zippoli M, Varrassi G, Allegretti M (2022) Emerging approaches for the management of Chemotherapy-induced peripheral neuropathy (CIPN): therapeutic potential of the C5a\/C5aR axis. Pain Ther 11:1113\u20131136. https:\/\/doi.org\/10.1007\/s40122-022-00431-8","journal-title":"Pain Ther"},{"key":"10262_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","volume":"28","author":"MG Strainic","year":"2008","unstructured":"Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, Shapiro VS, Dubyak GR, Heeger PS, Medof ME (2008) Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4\u2009+\u2009T cells. Immunity 28:425\u2013435. https:\/\/doi.org\/10.1016\/j.immuni.2008.02.001","journal-title":"Immunity"},{"key":"10262_CR35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/bph.12396","volume":"170","author":"J Tanaka","year":"2013","unstructured":"Tanaka J, Seki Y, Ishikura H, Tsubota M, Sekiguchi F, Yamaguchi K, Murai A, Umemura T, Kawabata A (2013) Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats. Br J Pharmacol 170:1233\u20131241. https:\/\/doi.org\/10.1111\/bph.12396","journal-title":"Br J Pharmacol"},{"key":"10262_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuropharm.2013.11.003","volume":"79","author":"J Tanaka","year":"2014","unstructured":"Tanaka J, Yamaguchi K, Ishikura H, Tsubota M, Sekiguchi F, Seki Y, Tsujiuchi T, Murai A, Umemura T, Kawabata A (2014) Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis. Neuropharmacology 79:112\u2013118. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.003","journal-title":"Neuropharmacology"},{"key":"10262_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102550","volume":"10","author":"M Tsubota","year":"2021","unstructured":"Tsubota M, Miyazaki T, Ikeda Y, Hayashi Y, Aokiba Y, Tomita S, Sekiguchi F, Wang D, Nishibori M, Kawabata A (2021) Caspase-dependent HMGB1 release from macrophages participates in peripheral neuropathy caused by Bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice. Cells 10:2550. https:\/\/doi.org\/10.3390\/cells10102550","journal-title":"Cells"},{"key":"10262_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1581-6","volume":"16","author":"M Tsubota","year":"2019","unstructured":"Tsubota M, Fukuda R, Hayashi Y, Miyazaki T, Ueda S, Yamashita R, Koike N, Sekiguchi F, Wake H, Wakatsuki S, Ujiie Y, Araki T, Nishibori M, Kawabata A (2019) Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin\/thrombomodulin system in rodents: negative impact of anticoagulants. J Neuroinflammation 16:199. https:\/\/doi.org\/10.1186\/s12974-019-1581-6","journal-title":"J Neuroinflammation"},{"key":"10262_CR39","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/bph.15091","volume":"178","author":"R Tsujita","year":"2021","unstructured":"Tsujita R, Tsubota M, Sekiguchi F, Kawabata A (2021) Role of high\u2010mobility group box 1 and its modulation by thrombomodulin\/thrombin axis in neuropathic and inflammatory pain. Br J Pharmacol 178:798\u2013812. https:\/\/doi.org\/10.1111\/bph.15091","journal-title":"Br J Pharmacol"},{"key":"10262_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11481-017-9773-2","volume":"13","author":"R Tsujita","year":"2018","unstructured":"Tsujita R, Tsubota M, Hayashi Y, Saeki H, Sekiguchi F, Kawabata A (2018) Role of thrombin in soluble Thrombomodulin-induced suppression of peripheral HMGB1-mediated allodynia in mice. J Neuroimmune Pharmacol 13:179\u2013188. https:\/\/doi.org\/10.1007\/s11481-017-9773-2","journal-title":"J Neuroimmune Pharmacol"},{"key":"10262_CR41","doi-asserted-by":"publisher","unstructured":"Vygonskaya M, Wu Y, Price TJ, Chen Z, Smith MT, Klyne DM, Han FY (2024) The role and treatment potential of the complement pathway in chronic pain. J Pain 104689. https:\/\/doi.org\/10.1016\/j.jpain.2024.104689","DOI":"10.1016\/j.jpain.2024.104689"},{"key":"10262_CR42","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.1701716","volume":"200","author":"J Xu","year":"2018","unstructured":"Xu J, Zhang L, Xie M, Li Y, Huang P, Saunders TL, Fox DA, Rosenquist R, Lin F (2018) Role of complement in a rat model of Paclitaxel-induced peripheral neuropathy. J Immunol 200:4094\u20134101. https:\/\/doi.org\/10.4049\/jimmunol.1701716","journal-title":"J Immunol"},{"key":"10262_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jphs.2016.01.005","volume":"130","author":"D Yamasoba","year":"2016","unstructured":"Yamasoba D, Tsubota M, Domoto R, Sekiguchi F, Nishikawa H, Liu K, Nishibori M, Ishikura H, Yamamoto T, Taga A, Kawabata A (2016) Peripheral HMGB1-induced hyperalgesia in mice: redox state-dependent distinct roles of RAGE and TLR4. J Pharmacol Sci 130:139\u2013142. https:\/\/doi.org\/10.1016\/j.jphs.2016.01.005","journal-title":"J Pharmacol Sci"},{"key":"10262_CR44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102034118","volume":"118","author":"H Yang","year":"2021","unstructured":"Yang H, Zeng Q, Silverman HA, Gunasekaran M, George SJ, Devarajan A, Addorisio ME, Li J, Tsaava T, Shah V, Billiar TR, Wang H, Brines M, Andersson U, Pavlov VA, Chang EH, Chavan SS, Tracey KJ (2021) Hmgb1 released from nociceptors mediates inflammation. Proc Natl Acad Sci U S A 118:e2102034118. https:\/\/doi.org\/10.1073\/pnas.2102034118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10262_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/17448069251321143","volume":"21","author":"MB Zhang","year":"2025","unstructured":"Zhang MB, Chen JL, Lu JH, Jia GL, Cao H, Li J (2025) SGK1-HDAC4-HMGB1 signaling pathway in the spinal cord dorsal horn participates in diabetic neuropathic pain. Mol Pain 21:17448069251321143. https:\/\/doi.org\/10.1177\/17448069251321143","journal-title":"Mol Pain"},{"key":"10262_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135758","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Keenan A, Dai DF, May KS, Anderson EE, Lindorfer MA, Henrich JB, Pitcher GR, Taylor RP, Smith RJ (2020) C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-\/- Cfd-\/-mice. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.135758","journal-title":"JCI Insight"},{"key":"10262_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1744-8069-8-55","volume":"8","author":"M Zhao","year":"2012","unstructured":"Zhao M, Isami K, Nakamura S, Shirakawa H, Nakagawa T, Kaneko S (2012) Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain 8:55. https:\/\/doi.org\/10.1186\/1744-8069-8-55","journal-title":"Mol Pain"},{"key":"10262_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/s0161-5890(99)00109-1","volume":"36","author":"J Zwirner","year":"1999","unstructured":"Zwirner J, Fayyazi A, Gotze O (1999) Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol 36:877\u2013884. https:\/\/doi.org\/10.1016\/s0161-5890(99)00109-1","journal-title":"Mol Immunol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-025-10262-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:02:55Z","timestamp":1762275775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-025-10262-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10262"],"URL":"https:\/\/doi.org\/10.1007\/s11481-025-10262-x","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by Kindai University\u2019s Committee for the Care and Use of Laboratory (Approval Number: KAPS-2022-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors agree to publish the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}